Publications page has been updated (MYC/glutamine dependency is a therapeutic vulnerability in pancreatic cancer with deoxycytidine kinase inactivation-induced gemcitabine resistance)
	
	Published: Wednesday, 08 February 2023	
	
	        
						    
	
メニュー